ERA

Download the full-sized PDF of The association between renal insufficiency, phamacotherapy, and outcomes in 6427 patients with heart failure and coronary artery disease.Download the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R3DW0J

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Nursing, Faculty of

Collections

This file is in the following collections:

Health Systems

The association between renal insufficiency, phamacotherapy, and outcomes in 6427 patients with heart failure and coronary artery disease. Open Access

Descriptions

Author or creator
Ezekowitz, J.
McAlister, F. A.
Humphries, K.H.
Norris, C.M.
Tonelli, M.
Ghali, W.A.
Knudtson, M.L.
Additional contributors
Subject/Keyword
renal insufficiency
cardiovascular medications
coronary artery disease
nursing research
Type of item
Journal Article (Published)
Language
English
Place
Time
Description
Objectives This study was designed to examine the use of cardiovascular medications and outcomes in patients with heart failure (HF) and renal dysfunction. Background Renal insufficiency is associated with poorer outcomes in patients with HF, but the mechanisms are uncertain. In particular, the degree of therapeutic nihilism in these patients, and whether it is appropriate, is unclear. Methods This was a prospective cohort study with a one-year follow-up. Results In 6,427 patients with cardiologist-diagnosed HF and angiographically proven coronary artery disease (mean age 69 years; 65% men; one-year mortality, 10%), 39% had creatinine clearances <60 ml/min. Patients with renal insufficiency were less likely to be prescribed angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, statins, or aspirin (all p < 0.001). However, users of aspirin (odds ratio [OR] 0.69, 95% confidence interval [CI] 0.57 to 0.85), statins (OR 0.79, 95% CI 0.64 to 0.97), and beta-blockers (OR 0.75, 95% CI 0.62 to 0.90) were less likely to die in the subsequent 12 months than nonusers, irrespective of renal function (all OR adjusted for covariates including atherosclerotic burden and ejection fraction). Although ACE inhibitor users with creatinine clearances ≥60 ml/min had lower 12-month mortality (OR 0.72, 95% CI 0.48 to 0.99), ACE inhibitor users with clearances <60 ml/min did not (OR 1.21, 95% CI 0.97 to 1.51). Conclusions Renal insufficiency is common in patients with HF and coronary artery disease, and these patients have more advanced coronary atherosclerosis. Patients with renal insufficiency are less likely to be prescribed efficacious therapies, but have better outcomes if they receive these medications.
Date created
2004
DOI
doi:10.7939/R3DW0J
License information
Rights
© 2004 Elsevier. This version of this article is open access and can be downloaded and shared. The original author(s) and source must be cited.
Citation for previous publication
Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA. The association between renal insufficiency, phamacotherapy, and outcomes in 6427 patients with heart failure and coronary artery disease. Journal of the American College of Cardiology 44.8 (2004), 1587:1592.
Source
Link to related item

File Details

Date Uploaded
Date Modified
2014-04-24T22:35:01.659+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 104513
Last modified: 2015:10:12 11:53:55-06:00
Filename: JACC_44_2004.pdf
Original checksum: 6c1e7763852a58f08e8438ecb5852275
Well formed: true
Valid: false
Status message: Invalid Resources Entry in document offset=4015
Status message: Invalid Resources Entry in document offset=4015
Status message: Outlines contain recursive references.
File title: The Association Among Renal Insufficiency, Pharmacotherapy, and Outcomes in 6,427 Patients With Heart Failure and Coronary Artery Disease
Page count: 6
Activity of users you follow
User Activity Date